The cold season is in full swing, throats are scratchy and noses are running. We feel ill and hope it is not the flu. The ...
When a virus infects a bacterial cell, the viral genome is the first component to be fully injected into the cell, making it an ideal immune target. A bacterial enzyme anchored to the membrane ...
The story of life’s beginnings gets stranger when you look closely at viruses. These tiny entities seem to sit at the edge of ...
Morning Overview on MSN
Newly found giant DNA Ushikuvirus may offer clues to cell evolution
A giant DNA virus pulled from a Japanese freshwater pond is forcing scientists to rethink how complex cells first acquired their defining feature: the nucleus. Named ushikuvirus, the newly ...
A study published in the journal Science reveals how jumping fragments of human DNA, a type of genetic parasite, destabilize the cancer genome. Unstable genomes are a fertile playground for cancer ...
Gene and cell therapy is moving fast – and in a clear direction. Programs are pushing toward more complex payloads, virus-free engineering, and manufacturing models that can scale from early research ...
News-Medical.Net on MSN
AI trained on 9 trillion DNA letters predicts harmful mutations and designs new genomes
By Hugo Francisco de Souza Trained on genomic data spanning the tree of life, Evo 2 reveals how artificial intelligence can decode the rules of DNA and even generate new functional sequences, opening ...
Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® ...
Colossal Biosciences’ CEO says its work follows a ‘moral obligation’ while critics say it’s ‘tech bro’ hype that could undermine conservation ...
Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for high unmet need diseases ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results